Becker's Healthcare April 1, 2025
CVS Caremark, Express Scripts and Optum Rx — the three largest pharmacy benefit managers in the U.S. — each excluded more than 600 drugs from their 2025 formularies, according to an April 1 blog post from the Drug Channels Institute.
The analysis is based on a review of the 2025 formulary exclusion lists published by the three PBMs, along with pricing data and publicly available product information for biosimilars and branded drugs.
Notably, PBMs are prioritizing their own private-label biosimilars over...
Today's Sponsors
Today's Sponsor